AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zysita M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Three Dots Lifescience

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Zysita M 50mg/500mg Tablet

Combiflex DM 50mg/500mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like nephropathy and visual impairment, potentially lowering the risk of cardiovascular events. Combiflex DM 50mg/500mg may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and concurrent medications. Ingestion with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Adherence to your doctor's dietary and exercise plan is crucial for effective diabetes management; lifestyle significantly impacts glycemic control. Common side effects include nausea, vomiting, diarrhea, abdominal distress, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; understanding hypoglycemia recognition and management is essential. This medication isn't universally suitable. Prior to use, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its potential to exacerbate hypoglycemia. Your physician will monitor renal function and blood glucose levels throughout treatment.

Uses of Zysita M 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Zysita M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire Zysita M 50mg/500mg tablet without crushing, chewing, or breaking it. Administer with food.

Common Side effects of Zysita M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Zysita M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zysita M 50mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Zysita M 50mg/500mg Tablet works:

Zysita M 50mg/500mg tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Zysita M 50mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zysita M 50mg/500mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Zysita M 50mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Zysita M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. The use of Zysita M 50mg/500mg tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Zysita M 50mg/500mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Zysita M 50mg/500mg Tablet :

Should you forget a Zysita M 50mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Zysita M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Zysita M 50mg/500mg Tablet

Zysita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Zysita M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Zysita M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Zysita M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Zysita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Zysita M 50mg/500mg Tablet. This rare complication is reason for caution in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Zysita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Zysita M 50mg/500mg Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Zysita M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Zysita M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Zysita M 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Zysita M 50mg/500mg Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Zysita M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Zysita M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Zysita M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Zysita M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Zysita M 50mg/500mg Tablets can cause lactic acidosis (MALA—Metformin-associated lactic acidosis), a serious medical emergency characterized by high blood lactic acid levels. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Zysita M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and urinary issues), and cognitive changes, including balance problems (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Zysita M 50mg/500mg Table...
284